P rompt, accurate detection and identification of bloodstream pathogens are essential for opti mal management of intensive care unit patients with sepsis syndromes. Healthcare facilities spend considerable resources in terms of labor and equip ment drawing, processing and analyzing blood cultures. Missed opportunities to document the true cause of blood stream infections can adversely affect patient outcome if the true causative organism is not identified and treated with an active antibiotic. Conversely, the identification of organisms in blood cultures that are contaminants can lead to the unnecessary administration of antimicrobial agents that will increase cost, increase toxicity, and distract the clinical team from treat ing the true causative agent. Thus, tech niques that are sensitive, specific, and rapid for identifying the microbial cause of sepsis are major operational tools for all critical care units, and intensivists must recognize that technology is revo lutionizing the tools that are being used.
For the past 30 yrs, healthcare sys tems have relied on techniques in which blood is incubated in various media, semiautomated instruments are used to monitor microbial growth, and organ isms are identified by Gram stain and biochemical tests. In recent years, clinical laboratories have begun to move to novel approaches: nucleic acid amplification tests and mass spectrometry are two of the most common approaches that have been introduced into clinical laboratories for routine detection and identification of organisms, and molecular tests are being used increasingly to rapidly iden tify microbial sequences that confer drug resistance. Clinicians must understand the sensitivities and specificities of results derived from both conventional diagnos tics and newer molecular approaches. The implications of using these technologies for the assessment of septic patients will be evaluated in this review.
Evolution of Conventional Blood Culture
Historically, blood cultures were per formed by inoculating a large volume of blood into one or more bottles of a nutrient medium after which the bottles were examined visually each day for evidence of microbial growth (e.g., visualization of discrete colonies, turbidity, gas production).
Instruments were introduced in the early 1970s that could automatically monitor the bottles for microbial growth (e.g., production of carbon dioxide) and alert staff when growth was detected. Subsequent refinements in both culture media and detection systems have improved the overall recovery and time to detection of organisms in septic patients while reducing labrelated contamination of cultures.
The value of blood cultures for con firming the clinical diagnosis of sepsis, severe sepsis, and septic shock (i.e., dis seminated infection from a localized focus such as meninges, lungs, abdomen, urinary tract, or from febrile neutropenia) is suboptimal. Although most untreated patients with bacterial meningitis have positive blood cultures, only 30% of patients with bacterial pneumonia and intraabdominal infections have positive cultures, and positive blood cultures in patients with urologic disease are primar ily restricted to those with acute pyelone phritis. Only 5% to 15% of the all cultures drawn for any reason, and only 50% of patients with septic shock, are positive. Whether the low rate for positive blood cultures is related to the sensitivity of the diagnostic techniques or the biology of the infectious process is unclear.
Contaminants represent 15% to 30% of the isolated organisms in some hos pitals. Overall, the success of recovering pathogens and eliminating contaminants is directly related to the techniques used Healthcare systems spend considerable resources collecting and processing blood cultures for the detection of blood stream pathogens. The process is initiated with the collection of blood cultures that depend upon proper skin disinfection, collection of an adequate number of specimens and volume of blood, and prompt processing in a sensitive culture system. Complementing blood cultures and gaining in use are techniques such as nucleic acid amplification tests and mass spectroscopy that allow clinical laboratories to detect and identify organisms from blood cultures substantially faster than conventional systems. Furthermore, certain resistance mutations can be detected within hours of organism detection, thus providing valuable guidance to clinicians who strive to initiate the appropriate antimicrobial therapy as rapidly as possible, and who wish to discontinue unnecessary drugs expeditiously. Molecular and mass spectroscopy techniques are changing sepsis diagnosis rapidly and will provide far more specific information far more quickly, but the performance characteristics of these systems must be understood by intensivists who use such information to guide their patient management. ( Patrick Murray is an employee of Becton Dickinson and has equity interest. Dr. Masur has not disclosed any potential conflicts of interest.
For information regarding this article, E-mail: hma-sur@nih.gov to collect and process blood cultures, and the patient population being evaluated.
Blood Culture Contaminants. Careful attention to the blood drawing and bottle inoculation techniques are important to maximize culture specificity for the true causative organism. This begins with careful disinfection of the phlebotomy site (1, 2) with 70% ethanol followed by application of chlorhexidine (30 secs) or tincture of iodine (1 min). Betadine prep arations are not recommended because they must be applied for 1.5-2 mins to be effective, and clinical staff are unlikely to wait for this long (3) . Catheter access sites as well as the rubber diaphragm on blood culture bottles should also be disinfected with 70% ethanol. The contamination rate should not exceed 2% to 3% of blood culture sets (a set consists of two to three bottles inoculated with a single blood col lection). Focused training for those draw ing such cultures is likely to result in substantial savings in terms of reducing the prevalence and consequences of con taminated cultures.
It is no longer recommended that the needle inserted at the phlebotomy site be replaced with a second needle before the blood is transferred to the blood culture bottles. Although there is a small decrease in contaminated cultures with such needle exchange (4), this benefit does not out weigh the risk to the phlebotomist of nee dleassociated injury (e.g., transmission of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, or rarely other pathogens), should there be a mishap in which the phlebotomist sustains a sharp injury while changing needles.
Current blood culture instruments are "closed" systems that detect microbial growth with external monitoring devices. This means that virtually all contami nants in blood cultures originate from the skin or intravenous catheter surface when the blood is collected and inoculated into bottles. Most contaminants are coagu lasenegative Staphylococci, Bacillus, Corynebacterium, or Propionibacterium. When these organisms are identified by the laboratory, clinicians should be suspicious that they represent contami nants, especially if they take >48-72 hrs to grow (suggesting they were present in small numbers) and are present in only one bottle or one set of bottles. However, these organisms can occasionally be true pathogens, especially in patients with implanted hardware (prosthetic valves, implanted cardiac devices, or mechani cal joints). When these pathogens grow in multiple bottles or in multiple blood cul ture sets, they need to be considered seri ously as true pathogens, especially if they are detected in <24-48 hrs (time of blood draw to time of laboratory detection).
Cultures Drawn From Catheters. Collection of blood cultures through intravascular devices was traditionally discouraged because the prevalence of contaminated cultures is slightly higher compared with venipuncture. However, as more and more patients have indwell ing intravascular devices, clinicians have recognized that blood draws through catheters can increase the likelihood of identifying the cause of sepsis because the catheter is often the infected nidus, and because patient phlebotomy can be difficult and painful when patients are in intensive care units for many days, have coagulation disorders, and are subjected to many intravascular accesses. In fact, the likelihood of obtaining contaminants by drawing blood through intravascular catheters is only slightly higher than the risk associated with venipuncture (5, 6) .
An important concept for interpreting the source of bacteremia and fungemia is the recognition that the "time to positiv ity" (time from when the blood culture was drawn until the positive result was detected by the automated system) is meaningful. If a culture drawn through one lumen is positive at least 90-120 mins before a culture drawn from another site (percutaneously or another catheter or lumen), the results suggest that the lumen with the earlier report of positivity has a higher concentration of organisms and is the source of the infection (7) .
Recent studies (8, 9) documented the need to culture all lumens in multilu men catheters to avoid missing a signifi cant number of catheterrelated septic events. However, for patients with mul tiple lumens and/or multiple catheters, drawing cultures from each lumen may not be feasible due to considerations of volume of blood required and cost of numerous cultures. Clinicians must then make a judgment as to which sites most merit culture. Such decisions are influ enced by which lumens are accessed most often, which lumens have recently failed to function optimally, physical findings of erythema or tenderness or exudates, and knowledge about the conditions under which the catheter was placed.
Effect of Blood Volume. The volume of blood cultured is a pivotal variable for the successful recovery of bloodstream patho gens: the more volume that is cultured, the higher the yield of the process (10) (11) (12) (13) (14) (15) . Cockerill et al (13) documented a 29.8% increase in positive cultures when 20 mL of blood (divided into two bottles) were cultured compared with 10 mL of blood. Additional positive cultures were observed when 30 mL (13.4% increase vs. 20 mL) and 40 mL of blood (7.2% in crease vs. 30 mL) were cultured. The blood culture yield also increases with the collection of additional blood cultures (consisting of 20 mL of blood divided into two bottles). Cockerill et al (13) also re ported that when a minimum of four blood culture sets were collected within a 24hr period, the yield increased with each additional culture drawn: 61.4% of the patients with blood stream pathogens had the causative organism detected with the first collected culture, 78.2% with the first two cultures, and 93.1% with the first three cultures. Lee et al (14) reported very similar data.
Whereas patients with catheterrelated sepsis, endocarditis, or other intravas cular infections may be persistently bacteremic, most other infections are associated with intermittent bacteremia or fungemia. Although it is commonly believed that highgrade seeding of the blood corresponds to temperature eleva tions, Riedel et al (16) demonstrated in a multicenter study that timing collection of blood cultures with temperature eleva tions did not increase the yield of blood cultures.
Because clinical signs including fever and symptoms cannot be used to pre dict the optimum time for specimen collection, the Society for Critical Care Medicine, Infectious Diseases Society of America, Surviving Sepsis Campaign, and Clinical and Laboratory Standards Com mittee recommend that a minimum of two blood cultures consisting of 20-30 mL per culture (ideally one peripheral draw and one drawn through the catheter most suspicious of being infected if line sepsis is suspected) should be collected within a 30min period when a septic patient is first evaluated, before antibiotics are administered or changed, and additional cultures should be collected over a 24hr period.
Recovery of Anaerobic Bacteria. Historically it was recommended that blood should be subdivided into an aero bic bottle (supports the growth of strict aerobic and facultatively anaerobic [grows aerobically or anaerobically] bacteria as well as yeasts) and an anaerobic bottle (supports growth of strict anaerobic and facultatively anaerobic bacteria). Retrospective studies analyzing positive blood cultures in the 1970s and 1980s documented poor recovery of anaerobic bacteria. Although laboratory recommen dations have evolved as various media have been developed and assessed, most laboratories currently favor use of an aerobic bottle and an anaerobic bottle for optimum recovery of a broad spectrum of bacteria and fungi (17) (18) (19) (20) .
Recovery of Fungi and Fastidious Bacteria. The use of special medium formulations for the recovery of yeasts is generally not necessary because most grow well in conventional aerobic blood culture broths within 2-3 days. Exceptions to this rule include Candida glabrata and Cryptococcus neoformans, which typically require 3-5 days of incu bation. Fusarium and Paecilomyces can be recovered in conventional blood cul ture broth, but most other filamentous fungi are not detected. Dimorphic molds such as Histoplasma and Blastomyces can grow in blood culture broths al though incubation for >2 weeks is re quired which is generally impractical. Use of supplementary systems such as the lysiscentrifugation system (Isolator, Wampole Laboratories, Cranbury, NY) is recommended for isolation of slowgrow ing molds and fastidious bacteria. Table 1 lists organisms that are unlikely to grow in standard blood culture sets and that require clinicians to alert the labo ratory for special processing in terms of selective media, different incubation tem peratures, or extended incubation times.
Antibiotic Inactivation Systems. Patients frequently receive antibiotics that suppress the growth of bacteria and fungi. Manufacturers of most blood cul ture systems supplement their media with proprietary formulations of anti bioticbinding resin beads or absorbent charcoal and Fuller's earth. Analysis of the performance of these compounds has demonstrated superior performance of the resins for removal of antibacterial and antifungal antibiotics, improved recovery of bacteria and fungi, and decreased time to detection of positive cultures (21-24). Thus, because these substances are now routinely used in culture systems, clini cians do not need to request "antibiotic removal systems" for cultures drawn in patients receiving antimicrobial therapy.
Detection Time. One significant ad vantage with the use of automated blood culture systems that continuously moni tor microbial growth throughout the incubation period is early detection of positive cultures. More than 90% of all positive blood cultures are detected with in the first 48 hrs of incubation (13, 25) , and extended incubation beyond 5-7 days is rarely indicated unless the pathogens listed in Table 1 are suspected (26, 27).
One underappreciated fact is that sig nificant delays between collection of blood cultures and initiation of incubation will prolong detection times. These delays can occur both at the patient's bedside and in the laboratory. Kerremans et al (28, 29) and van der Velden et al (30) demon strated in a series of elegant studies that incubation delays for almost half of all blood cultures exceeded 4 hrs (including median transport times of 3.9 hrs and 16.0 hrs for specimens from the intensive care unit and emergency department, respec tively), preincubation at the collection site significantly reduced the time to detection of positive cultures, and this resulted in more rapid adjustment of antibiotic ther apy. Although blood culture instruments are rarely used outside the clinical lab, the installation of such instruments proxi mate to intensive care units should be considered in high volume settings where transport delays are likely.
Molecular-Based Techniques
Detection of Bacteremia and Fungemia. There is great interest in mo lecular techniques to diagnose sepsis in blood samples taken directly from patients (31, 32). The goal is diagnosis of bacte remia or fungemia with simultaneous detection of resistance genes with results available in a few hours after specimen acquisition. However, such techniques are not yet optimally developed: current techniques for amplification of microbial DNA for the detection and identification of microorganisms in blood samples such as the SeptiFast system (Roche Molecular Systems) have poor sensitivity and speci ficity, are technically cumbersome requir ing specimen batching and a minimum of 6 hrs processing time, and provide no information about antimicrobial suscep tibility results (33-36). It can be argued that these tests should be used as comple mentary tests to traditional culture, and economic models have been developed that purport rapid polymerase chain reaction identification of microorgan isms that has the potential to be a cost effective component for managing sepsis (37); however, these models assume the molecular tests have sufficient sensitivity to detect all significant organisms with a single test, are specific and detection of microbial DNA in blood is always clini cally significant, and are performed in a hospital population where there is a high proportion of inadequate empirical ther apy (38). Despite the current limitations of molecular sepsis tests, we believe it is appropriate to be optimistic that the rapid progress in technology development will make such direct sample testing feasible and useful in the near future, potentially as point of care testing in emergency de partments and intensive care units.
Microbial Identification. New ap proaches are having impact on the identification of organisms once the or ganism is growing in the blood culture broth. The traditional approach for pro cessing a positive blood culture is to re move a portion of the broth, subculture it to agar media, and after overnight in cubation select isolated colonies for iden tification and antimicrobial susceptibility tests. This process requires 1-3 days be fore definitive results are available. The use of fluorescence in situ hybridization using peptide nucleic acid probes (PNA FISH) has been used for direct identifi cation of Staphylococcus, Enterococcus, Klebsiella, and Candida species in posi tive blood cultures (39-42) in <2 hrs. This identification approach is laborious because individual probes have to be cre ated for each species. More promising is mass spectrom etry that can identify organisms (but not detect antibiotic susceptibility) within an hour or less from the culture broth, that is, from the time the system alarm alerts the technician of growth. Mass spectrometry, specifically matrixassisted laser desorption/ionization timeofflight (MALDITOF) mass spectrometry, has been used for identification of isolated colonies of bacteria and fungi and is rapidly replacing biochemical and gene sequencing methods for organism iden tification because it is highly accurate, inexpensive, and results are available in <1 hr. MALDITOF can also be used for the direct identification of bacteria and yeasts isolated in blood culture broths (43-49). Processing these specimens is more complex because the nonmicrobial cells, serum proteins, and broth culture nutrients must be removed before the microbial cells are evaluated. However, definitive identification results from posi tive blood culture broths are generally available in <1 hr after the technician is alerted to growth. Approximately 15% to 20% of the isolates are not initially identified primarily because insufficient numbers of cells are in the positive blood culture broth (e.g., skin bacteria such as coagulasenegative Staphylococci and Corynebacteria). However, modification of the extraction procedures is improv ing the test sensitivity (50, 51). It should be noted that not all blood culture broth formulations produce adequate results, particularly media supplemented with charcoal (52-54). This technique has not been used reliably on direct patient speci mens, for example, blood samples.
Antimicrobial Susceptibility Tests. The ability to obtain a definitive identification of a positive blood culture isolate within 1 hr of detection can be used to guide empiric therapy. Although the results of most antimicrobial susceptibility tests are not available for 8-24 hrs, 1 to 2hr poly merase chain reaction tests for the pres ence of genes that encode resistance to oxacillin, vancomycin, and the carbapen emases are commercially available and used in many clinical laboratories. These tests are useful; however, the tests may provide misleading results because they do not measure if the resistance gene is expressed. For example, presence of the mecA gene is associated with methicil lin resistance in Staphylococcus aureus, and the vanA gene is associated with van comycin resistance in Enterococcus faecium. If the regulatory genes that control expression of these resistance markers are inoperable, then the bacteria will remain drug susceptible, and the gene detection assay would mislead the clinician (55, 56). Likewise, the absence of mecA or vanA cannot be used to predict susceptibility to methicillin or vancomycin because resis tance to the antibiotic may be the result of another mechanism. For this reason, assessment of antibiotic susceptibility by genomic techniques should be con sidered a presumptive test that must be confirmed by the current phenotypic tests that assess the growth of bacteria in the presence of the test antibiotic. It is likely that rapid susceptibility tests will con tinue to evolve beyond the detection of resistance gene sequences or detection of growing organisms by visual methods and ultimately rely on early detection of the response to antibiotics by measuring gene expression or metabolic activity without the need for cell division.
CONCLUSIONS
Molecular and mass spectroscopy techniques are changing sepsis diagnosis rapidly. These techniques provide sub stantially more rapid and more specific information on organism identification and on the presence of resistance mech anisms than conventional brothbased techniques. Critical care physicians will have to expeditiously learn what infor mation to expect from such systems, and how such information can be used to assure that initial antimicrobial regimens are appropriate, and the unnecessary drugs are discontinued. These techniques are expected to contribute substantially to improving antibiotic stewardship and to improving "time to appropriate antibiotics," one of the most pivotal parameters in improving the prognosis of patients with lifethreatening infections. 
